Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > MORF Morphic > Detailed Quotes

MORF Morphic

28.770
+1.960+7.31%
Close 09/28 16:00 ET
28.7700.0000.00%
Post Mkt Price 09/28 16:01 ET
High
29.080
Open
27.300
Turnover
24.17M
Low
26.580
Pre Close
26.810
Volume
846.56K
Market Cap
1.11B
P/E(TTM)
Loss
52wk High
68.750
Shares
38.48M
P/E(Static)
Loss
52wk Low
19.230
Float Cap
740.37M
Bid/Ask %
-33.33%
Historical High
93.000
Shs Float
25.73M
Volume Ratio
2.23
Historical Low
9.900
Dividend TTM
--
Div Yield TTM
--
P/B
2.85
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
3.29%
Amplitude
9.33%
Avg Price
28.550
Lot Size
1
Float Cap
740.37M
Bid/Ask %
-33.33%
Historical High
93.000
Shs Float
25.73M
Volume Ratio
2.23
Historical Low
9.900
Dividend TTM
--
P/B
2.85
Dividend LFY
--
Turnover Ratio
3.29%
Amplitude
9.33%
Avg Price
28.550
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Morphic Holding, Inc. operates as a biopharmaceutical company, which engages in the research and development of oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.
CEO: Dr. Praveen P. Tipirneni, M.D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...